BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 16393209)

  • 1. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study.
    Solaymani-Dodaran M; Logan RF; West J; Card T
    Am J Gastroenterol; 2005 Dec; 100(12):2616-21. PubMed ID: 16393209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Scand J Gastroenterol; 2004 Jul; 39(7):680-5. PubMed ID: 15370691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barrett's esophagus-is it bad for your health?
    Falk GW
    Am J Gastroenterol; 2005 Dec; 100(12):2622-3. PubMed ID: 16393210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
    Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
    Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of Barrett's esophagus.
    Clark GW; DeMeester TR
    Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):727-31. PubMed ID: 18349295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat Reflux Model of Esophageal Cancer and Its Implication in Human Disease.
    Greene CL; Worrell SG; DeMeester TR
    Ann Surg; 2015 Dec; 262(6):910-24. PubMed ID: 25822684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in Barrett's esophagus: three decades of experience at a single center.
    Caygill CP; Royston C; Charlett A; Wall CM; Gatenby PA; Ramus JR; Watson A; Winslet M; Bardhan KD
    Endoscopy; 2012 Oct; 44(10):892-8. PubMed ID: 22752886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
    Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cause-specific mortality of people with Barrett's esophagus compared with the general population: a population-based cohort study.
    Solaymani-Dodaran M; Card TR; West J
    Gastroenterology; 2013 Jun; 144(7):1375-83, 1383.e1. PubMed ID: 23583429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Proton Pump Inhibitors on Barrett's Esophagus.
    Dunbar KB; Souza RF; Spechler SJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):415-24. PubMed ID: 26021202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptoms, acid exposure and motility in patients with Barrett's esophagus.
    Brandt MG; Darling GE; Miller L
    Can J Surg; 2004 Feb; 47(1):47-51. PubMed ID: 14997925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroesophageal reflux disease and Barrett's esophagus.
    Anand O; Wani S; Sharma P
    Endoscopy; 2008 Feb; 40(2):126-30. PubMed ID: 18058620
    [No Abstract]   [Full Text] [Related]  

  • 19. From reflux esophagitis to Barrett's esophagus and esophageal adenocarcinoma.
    Wang RH
    World J Gastroenterol; 2015 May; 21(17):5210-9. PubMed ID: 25954094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.
    Anderson LA; Cantwell MM; Watson RG; Johnston BT; Murphy SJ; Ferguson HR; McGuigan J; Comber H; Reynolds JV; Murray LJ
    Gastroenterology; 2009 Mar; 136(3):799-805. PubMed ID: 19162028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.